Fundz

Alltrna Announces Series B Raise Of $109 Million To Advance Trna Medicines For Stop Codon Disease

PRIVATEAug 09, 2023

Round Type

Series B

CambridgeBiotechnologyHealth CareArtificial IntelligenceTherapeutics

Investors

Flagship Pioneering

Description

Alltrna, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA medicines to regulate the protein universe and resolve disease, today announced that it has raised $109 million in a Series B financing to advance the company's platform and first drug candidates towards the clinic for a first indication in Stop Codon Disease. The financing round included the company's founder, Flagship Pioneering, and a number of top-tier investors.

Quick answer

Alltrna raised an undisclosed amount in a Series B round, dated August 9, 2023. Investors: Flagship Pioneering. Alltrna is based in Cambridge, Massachusetts, United States.

How much did Alltrna raise?
Alltrna raised an undisclosed amount in a Series B round on August 9, 2023.
Who invested in Alltrna?
Flagship Pioneering is named as investors in this round.
What does Alltrna do?
Alltrna unlocks tRNA biology to treat disease.
Where is Alltrna based and how big is it?
Alltrna is based in Cambridge, Massachusetts, United States.
Who are the decision-makers at Alltrna?
Fundz holds 1 contact at Alltrna. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Alltrna that raised within 45 days of this round, from Fundz verified event records.

  • PredxBio raised $601K (Seed) on August 4, 2023.
  • Qihan Biotech raised an undisclosed amount (Series B) on September 23, 2023.
  • IOMED raised an undisclosed amount (Funding Round) on September 13, 2023.
  • DalCor Pharmaceuticals raised $80M (Series D) on September 13, 2023.
  • Renibus Therapeutics raised an undisclosed amount (Series B) on September 12, 2023.
  • Grit Biotechnology raised $60M (Series B) on September 8, 2023.

Who to call at Alltrna, and when

A new round usually means Alltrna is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Alltrna raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Alltrna, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Alltrna. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Alltrna

Location

Cambridge, Massachusetts, United States

About

Alltrna unlocks tRNA biology to treat disease. The company’s platform incorporates AI/ML tools to develop and deliver diverse programmable molecules with broad therapeutic potential. Alltrna has an unprecedented opportunity to advance a single tRNA medicine to readthrough premature stop codons and unify treatment across a wide range of diseases with the same underlying genetic mutations. Alltrna was founded in 2018 by Flagship Pioneering.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Alltrna raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Alltrna's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Alltrna raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.